Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature

Antoni Ribas, Caroline Robert, F. Stephen Hodi, Jedd D. Wolchok, Anthony M. Joshua, Wen-Jen Hwu, Jeffrey S. Weber, Hassane M. Zarour, Richard Kefford, Andrey Loboda, Andrew Albright, Soonmo Peter Kang, Scot Ebbinghaus, Jennifer Yearley, Erin Murphy, Michael Nebozhyn, Jared K. Lunceford, Terri McClanahan, Mark Ayers, Adil Daud

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)3001
Number of pages1
JournalJournal of Clinical Oncology
Volume33
Issue number15 supplement
DOIs
Publication statusPublished - 20 May 2015
EventAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States
Duration: 31 May 20134 Jun 2013

Cite this